Open access · CC-BY
via OpenAlex
Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease
Naijian Li, Zhouli Dai, Zhang Wang, Zhishan Deng, Jiahuan Zhang, Jinding Pu, Weitao Cao, Tianhui Pan, Yumin Zhou, Zhaowei Yang, Jing Li, Bing Li, Pixin Ran
Respiratory Research · 2021 · ▲ 195 citations
Abstract
BACKGROUND: Dysbiosis of the gut microbiome is involved in the pathogenesis of various diseases, but the contribution of gut microbes to the progression of chronic obstructive pulmonary disease (COPD) is still poorly understood. METHODS: We carried out 16S rRNA gene sequencing and short-chain fatty acid analyses in stool samples from a cohort of 73 healthy controls, 67 patients with COPD of GOLD stages I and II severity, and 32 patients with COPD of GOLD stages III and IV severity. Fecal microbiota from the three groups were then inoculated into recipient mice for a total of 14 times in 28 days to induce pulmonary changes. Furthermore, fecal microbiota from the three groups were inoculated into mice exposed to smoke from biomass fuel to induce COPD-like changes. RESULTS: We observed that the gut microbiome of COPD patients varied from that of healthy controls and was characterized by a distinct overall microbial diversity and composition, a Prevotella-dominated gut enterotype and lower levels of short-chain fatty acids. After 28 days of fecal transplantation from COPD patients, recipient mice exhibited elevated lung inflammation. Moreover, when mice were under both fecal transplantation and biomass fuel smoke exposure for a total of 20 weeks, accelerated declines in lung function, severe emphysematous changes, airway remodeling and mucus hypersecretion were observed. CONCLUSION: These data demonstrate that altered gut microbiota in COPD patients is associated with disease progression in mice model.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s12931-021-01872-z
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Li, N., Dai, Z., Wang, Z., Deng, Z., Zhang, J., Pu, J., Cao, W., Pan, T., Zhou, Y., Yang, Z., Li, J., Li, B., & Ran, P. (2021). Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. <em>Respiratory Research</em>. https://doi.org/10.1186/s12931-021-01872-z
Vancouver
Li N, Dai Z, Wang Z, Deng Z, Zhang J, Pu J, et al. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. Respiratory Research. 2021. doi:10.1186/s12931-021-01872-z.
BibTeX
@article{naijian2021Gutmic,
title = {Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease},
author = {Naijian Li and Zhouli Dai and Zhang Wang and Zhishan Deng and Jiahuan Zhang and Jinding Pu and Weitao Cao and Tianhui Pan and Yumin Zhou and Zhaowei Yang and Jing Li and Bing Li and Pixin Ran},
journal = {Respiratory Research},
year = {2021},
doi = {10.1186/s12931-021-01872-z},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Gut 2022
Preprint · OA
Gut microbiota regulate Alzheimer’s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation
Microbiome 2017
Open access · CC-BY
Gut microbiota dysbiosis contributes to the development of hypertension
Arthritis & Rheumatology 2022
Open access · CC-BY
Both Disease Activity and HLA–B27 Status Are Associated With Gut Microbiome Dysbiosis in Spondyloarthritis Patients
Journal of Alzheimer s Disease 2021
Citation only
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer’s Disease or Mild Cognitive Impairment
npj Biofilms and Microbiomes 2021
Open access · CC-BY
Metagenomic analysis revealed the potential role of gut microbiome in gout
Journal of Translational Medicine 2019
Open access · CC-BY